MIDATECH PHARMA PLC-ADR (MTP)
US59564R5000 - ADR
| MRQ (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 6.42M | 10.06M | 7.55M | 10.93M | 2.34M | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | 2.34M | |||
| Receivables | 2.27M | 1.10M | 1.47M | 2.81M | 3.27M | |||
| Inventories | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Other Current Assets | N/A | 607.00K | 258.00K | N/A | -330.00K | |||
| Total Current Assets | 8.69M | 11.76M | 9.28M | 13.74M | 5.62M | |||
| Non-Current Assets | ||||||||
| PPE Net | 993.00K | 1.15M | 542.00K | 2.15M | 1.98M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | 0.00 | 0.00 | 2.29M | 2.29M | |||
| Intangibles | N/A | 0.00 | 0.00 | 10.09M | 10.08M | |||
| Total Non-Current Assets | 993.00K | 1.15M | 542.00K | 17.16M | 14.83M | |||
| TOTAL ASSETS | 9.68M | 12.91M | 9.82M | 30.89M | 20.44M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 167.00K | 146.00K | 200.00K | 412.00K | 368.00K | |||
| Accrued Expenses | N/A | 546.00K | 768.00K | 1.76M | 1.02M | |||
| Accounts Payable | 1.28M | 485.00K | 337.00K | 725.00K | 286.00K | |||
| Other Current Liabilities | 198.00K | 664.00K | 1.68M | 2.77M | 792.00K | |||
| Total Current Liabilities | 1.65M | 1.84M | 2.99M | 5.67M | 2.47M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 546.00K | 620.00K | 60.00K | 5.67M | 884.00K | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 50.00K | 0.00 | 165.00K | |||
| Total Non-Current Liabilities | 546.00K | 620.00K | 110.00K | 5.67M | 1.05M | |||
| TOTAL LIABILITIES | 2.19M | 2.46M | 3.10M | 11.34M | 3.52M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -77.04M | -74.08M | -68.71M | -46.84M | -36.72M | |||
| Additional Paid In Capital | 83.43M | 83.43M | 74.36M | 65.88M | 52.94M | |||
| Common Shares | 1.10M | 1.10M | 1.06M | 1.02M | 1.00M | |||
| Other Shareholders' Equity | N/A | 0.00 | 0.00 | -508.00K | -301.00K | |||
| Shares Outstanding | 6.94M | 6.93M | 4.44M | 1.65M | 218.62K | |||
| Tangible Book Value per Share | 0.08 | 0.11 | 0.11 | 0.31 | 1.47 | |||
| Total Shareholders' Equity | 7.49M | 10.45M | 6.72M | 19.56M | 16.92M | |||
| TOTAL LIABILITIES AND EQUITY | 9.68M | 12.91M | 9.82M | 30.89M | 20.44M | |||
| Statistics | ||||||||
| Debt/Equity | 0.07 | 0.06 | 0.01 | 0.29 | 0.05 | |||
| Current Ratio | 5.28 | 6.39 | 3.10 | 2.42 | 2.27 | |||
| Return On Assets (ROA) | -55.43% | -42.28% | -226.03% | -32.64% | -73.52% | |||
| Return On Equity (ROE) | -71.65% | -52.24% | -330.29% | -51.56% | -88.81% | |||
All data in GBP